EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Synthesis and neuroprotective activity of 3‐aryl‐3‐azetidinyl acetic acid methyl ester derivatives

Urtė Šachlevičiūtė, Gabriel Gonzalez, Marie Kvasnicová iD, Šárka Štěpánková iD, Neringa Kleizienė iD, Aurimas Bieliauskas iD, Marek Zatloukal iD, Miroslav Strnad iD, Frank A Sløk, Miroslav Kvasnica iD, Algirdas Šačkus iD, Asta Žukauskaitė

Archiv der Pharmazie · 2023-12 · 356 (12)

DOI: 10.1002/ardp.202300378 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archiv der Pharmazie, online erschienen am 05.10.2023. Verfasst von Urtė Šachlevičiūtė und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Synthetic Chemistry, Kaunas University of Technology, Kaunas, Lithuania. Hauptthemen laut MEDLINE: Alzheimer Disease, Neuroprotective Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Doctoral Fund of Kaunas University of Technology No. A-410, Approved 26 June 2019, Vipergen ApS, European Regional Development Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A library of 3‐aryl‐3‐azetidinyl acetic acid methyl ester derivatives was prepared from N ‐Boc‐3‐azetidinone employing the Horner‐Wadsworth‐Emmons reaction, rhodium(I)‐catalyzed conjugate addition of arylboronic acids, and subsequent elaborations to obtain N ‐unprotected hydrochlorides, N ‐alkylated and N ‐acylated azetidine derivatives. The compounds were evaluated for acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) inhibitory activity, revealing several derivatives to possess AChE inhibition comparable to that of the AChE inhibitor rivastigmine. The binding mode of the AChE inhibitor donepezil and selected active compounds 26 and 27 within the active site of AChE was studied using molecular docking. Furthermore, the neuroprotective activity of the prepared compounds was evaluated in models associated with Parkinson's disease (salsolinol‐induced) and aspects of Alzheimer's disease (glutamate‐induced oxidative damage). Compound 28 showed the highest neuroprotective effect in both salsolinol‐ and glutamate‐induced neurodegeneration models, and its protective effect in the glutamate model was revealed to be driven by a reduction in oxidative stress and caspase‐3/7 activity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseNeuroprotective AgentsHumansButyrylcholinesteraseAcetylcholinesteraseMolecular Docking SimulationStructure-Activity RelationshipCholinesterase InhibitorsGlutamatesAcetates

Stichwörter der Autor:innen

Alzheimer diseaseParkinson diseaseacetylcholinesteraseazetidineneuroprotection

Substanzen

ButyrylcholinesteraseAcetylcholinesteraseCholinesterase InhibitorsNeuroprotective AgentsGlutamatesmethyl acetateAcetates

Autor:innen und Institutionen

  • Institute of Synthetic Chemistry, Kaunas University of Technology, Kaunas, Lithuania.
  • Department of Experimental Biology, Faculty of Science, Palacký University Olomouc, Olomouc, Czech Republic.
  • Department of Neurology, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacký University Olomouc, Olomouc, Czech Republic.
  • Department of Biological and Biochemical Sciences, Faculty of Chemical Technology, University of Pardubice, Pardubice, Czech Republic.
  • Department of Chemical Biology, Faculty of Science, Palacký University, Olomouc, Czech Republic.
  • Laboratory of Growth Regulators, Institute of Experimental Botany of the Czech Academy of Sciences & Palacký University, Olomouc, Czech Republic.

ORCID-Profile: Marie Kvasnicová, Šárka Štěpánková, Neringa Kleizienė, Aurimas Bieliauskas, Marek Zatloukal, Miroslav Strnad, Miroslav Kvasnica, Algirdas Šačkus

Förderung

  • Doctoral Fund of Kaunas University of Technology No. A-410, Approved 26 June 2019
  • Vipergen ApS
  • European Regional Development Fund
  • Czech Science Foundation

Zitieren

APA

Šachlevičiūtė, U., Gonzalez, G., Kvasnicová, M., Štěpánková, Š., Kleizienė, N., Bieliauskas, A., Zatloukal, M., Strnad, M., Sløk, F. A., Kvasnica, M., Šačkus, A., & Žukauskaitė, A. (2023). Synthesis and neuroprotective activity of 3‐aryl‐3‐azetidinyl acetic acid methyl ester derivatives. Archiv der Pharmazie, 356(12). https://doi.org/10.1002/ardp.202300378

Vancouver

Šachlevičiūtė U, Gonzalez G, Kvasnicová M, Štěpánková Š, Kleizienė N, Bieliauskas A, et al. Synthesis and neuroprotective activity of 3‐aryl‐3‐azetidinyl acetic acid methyl ester derivatives. Archiv der Pharmazie. 2023;356(12). doi:10.1002/ardp.202300378

BibTeX
@article{achleviit2023,
  author = {Šachlevičiūtė, Urtė and Gonzalez, Gabriel and Kvasnicová, Marie and Štěpánková, Šárka and Kleizienė, Neringa and Bieliauskas, Aurimas and Zatloukal, Marek and Strnad, Miroslav and Sløk, Frank A and Kvasnica, Miroslav and Šačkus, Algirdas and Žukauskaitė, Asta},
  title = {Synthesis and neuroprotective activity of 3‐aryl‐3‐azetidinyl acetic acid methyl ester derivatives},
  journal = {Archiv der Pharmazie},
  year = {2023},
  volume = {356},
  number = {12},
  doi = {10.1002/ardp.202300378}
}
Kostenlos starten →